{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:37:11Z","timestamp":1791434231980,"version":"4.3.3"},"reference-count":20,"publisher":"BMJ","issue":"4","funder":[{"name":"Horne Family Charitable Trust"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2025,1,8]]},"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1136\/pn-2024-004459","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T01:20:41Z","timestamp":1737336041000},"page":"300-302","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Assisted reproduction technology in multiple sclerosis"],"prefix":"10.1136","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8760-4820","authenticated-orcid":false,"given":"Ger","family":"Mullan","sequence":"first","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Hughes","sequence":"additional","affiliation":[{"name":"Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rog","sequence":"additional","affiliation":[{"name":"Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brex","sequence":"additional","affiliation":[{"name":"Department of Neurology, King's College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-585X","authenticated-orcid":false,"given":"Ruth","family":"Dobson","sequence":"additional","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK"},{"name":"Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,19]]},"reference":[{"key":"2025090410323166000_25.4.300.1","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2023-003922"},{"key":"2025090410323166000_25.4.300.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102541"},{"key":"2025090410323166000_25.4.300.3","first-page":"493","article-title":"Multiple Sclerosis in Pregnancy and its Role in Female Fertility: A Systematic Review","volume":"25","author":"lamaita","year":"2021","journal-title":"JBRA"},{"key":"2025090410323166000_25.4.300.4","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1212\/01.wnl.0000208521.10685.a6","article-title":"Increase in multiple sclerosis relapse rate following in vitro fertilization","volume":"66","author":"Laplaud","year":"2006","journal-title":"Neurology (ECronicon)"},{"key":"2025090410323166000_25.4.300.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0607-2"},{"key":"2025090410323166000_25.4.300.6","doi-asserted-by":"publisher","DOI":"10.1159\/000177937"},{"key":"2025090410323166000_25.4.300.7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23745"},{"key":"2025090410323166000_25.4.300.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-302235"},{"key":"2025090410323166000_25.4.300.9","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519865118"},{"key":"2025090410323166000_25.4.300.10","first-page":"e1916","article-title":"Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis","volume":"99","author":"Mainguy","year":"2022","journal-title":"Neurology (ECronicon)"},{"key":"2025090410323166000_25.4.300.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000200106","article-title":"Inflammatory Activity After Diverse Fertility Treatments: A Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era","volume":"10","author":"Graham","year":"2023","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"2025090410323166000_25.4.300.12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00415-016-8041-3","article-title":"Two cases of multiple sclerosis manifesting after in vitro fertilization procedures","volume":"263","author":"Ladwig","year":"2016","journal-title":"J Neurol"},{"key":"2025090410323166000_25.4.300.13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jns.2014.11.016","article-title":"Tumefactive demyelination following in vitro fertilization (IVF)","volume":"348","author":"Vaknin-Dembinsky","year":"2015","journal-title":"J Neurol Sci"},{"key":"2025090410323166000_25.4.300.14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.fertnstert.2022.10.027","article-title":"Assisted reproductive technology treatment and risk of multiple sclerosis - a Danish cohort study","volume":"119","author":"Kopp","year":"2023","journal-title":"Fertil Steril"},{"key":"2025090410323166000_25.4.300.15","unstructured":"Fertility treatment 2019: trends and figures . Human fertilisation & embryology authority. 2021. Available: https:\/\/www.hfea.gov.uk\/about-us\/publications\/research-and-data\/fertility-treatment-2019-trends-and-figures\/ [Accessed 19 Oct 2024]."},{"key":"2025090410323166000_25.4.300.16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40263-023-01036-1","article-title":"Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis","volume":"37","author":"Sparaco","year":"2023","journal-title":"CNS Drugs"},{"key":"2025090410323166000_25.4.300.17","doi-asserted-by":"crossref","first-page":"105893","DOI":"10.1016\/j.msard.2024.105893","article-title":"Multiple sclerosis: Pregnancy, fertility, and assisted reproductive technology\u2013a review","volume":"92","author":"Oreja-Guevara","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"2025090410323166000_25.4.300.18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/practneurol-2018-002060","article-title":"UK consensus on pregnancy in multiple sclerosis: \u201cAssociation of British Neurologists\u201d guidelines","volume":"19","author":"Dobson","year":"2019","journal-title":"Pract Neurol"},{"key":"2025090410323166000_25.4.300.19","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2022-003426"},{"key":"2025090410323166000_25.4.300.20","doi-asserted-by":"crossref","unstructured":"Vukusic S , Bove R , Dobson R , et al . Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab. Neurol Neuroimmunol Neuroinflamm 2025;12. doi:10.1212\/NXI.0000000000200349","DOI":"10.1212\/NXI.0000000000200349"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/pn-2024-004459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T17:32:42Z","timestamp":1757007162000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/pn-2024-004459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,19]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,7,14]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/pn-2024-004459"],"URL":"https:\/\/doi.org\/10.1136\/pn-2024-004459","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,19]]}}}